DuPont Q4 2019 Earnings Report
Key Takeaways
DuPont's Q4 2019 net sales were $5.2 billion, a 5% decrease compared to the same quarter last year, with organic sales down 2%. Adjusted EPS decreased by 34% to $0.95, driven by lower segment results and a higher tax rate. The company is planning a merger of its Nutrition & Biosciences business with IFF.
Net sales for the quarter totaled $5.2 billion, down 5 percent versus the same quarter last year.
GAAP EPS from continuing operations totaled $0.24 versus pro forma GAAP EPS from continuing operations in the year-ago period of $0.39.
Adjusted EPS decreased 34 percent to $0.95, compared with pro forma adjusted EPS in the year-ago period of $1.43.
The planned merger of DuPont's N&B business with IFF was announced.
DuPont
DuPont
DuPont Revenue by Segment
DuPont Revenue by Geographic Location
Forward Guidance
DuPont anticipates full year 2020 sales between $21.5 and $22.0 billion, resulting in organic sales slightly up versus prior year. Adjusted EPS is expected to be in the range of $3.70 - $3.90.
Positive Outlook
- Full year sales between $21.5 and $22.0 billion.
- Organic sales are expected to be slightly up versus prior year.
- Adjusted EPS in the range of $3.70 - $3.90.
- Strong organic growth across core segments.
- Continued productivity and cost actions.
Challenges Ahead
- Headwinds from prior year discrete benefits.
- Nylon market pressures.
- Nylon headwinds being most impactful at the start of the year.
- Temporary manufacturing challenges in S&C.
- First quarter net sales expected to be down mid-single digits.
Revenue & Expenses
Visualization of income flow from segment revenue to net income